A significant shift in the country's drug policy has occurred, as the regulators allow the use of psilocybin fungi for therapeutic applications. Until now, these substances were severely restricted, but a mounting body of studies suggests they potentially offer benefits for psychological illnesses like depression. The new policy represents a substa